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arthritis (OA) as an outcome measure in clinical
trials of structure modifying drugs and in epi-
demiological studies. This review summarizes the
results obtained and the key points to consider
when using plain X-rays. The influence of di#erent
radiographic techniques on radiological findings is
reviewed with particular emphasis on the need for
standardization of radiographic procedures and
the di#erent views possible (extended view, semi-
flexed view, flexed view). The properties of these
di#erent views are discussed. Factors a#ecting
structural disease progression, such as demo-
graphic data and characteristics of OA (localiz-
ation, structural severity, symptomatic severity,
biological status) are reviewed. Suggestions are
made regarding the presentation of results and the
data analysis of studies in OA using radiographic
outcome assessment.
Osteoarthritis (OA) is a disorder which a#ects
synovial joints, particularly the hip and the knee.
The process is characterized on the basis of struc-
tural changes in articular cartilage and periarticu-
lar bone [1]. Pain severity and development of
severe disability are important outcome measures
in OA. However, it seems reasonable to employ
surrogates such as radiological modification to
assess disease progression in OA [2–7]. In cross-
sectional studies, structural changes are classi-
cally poorly related to the severity of joint pain or
disability [8]. However, a relationship between
changes in clinical parameters and changes in
radiological parameters has been recently demon-
strated in longitudinal studies [9].
Radiographic assessment is widely used as an
outcome measure of the structural severity of OA
in clinical trials of structure-modifying drugs and222in epidemiological studies [2–7]. This objective
method of quantifying disease has several advan-
tages [10, 11]. Plain radiographs are inexpensive,
widely available and require no special facilities.
The resulting films are a permanent record. They
can be randomly assigned and read blind to clini-
cal data. Films taken at di#erent times or in
di#erent centres can be easily assessed simul-
taneously by the same reader. Plain radiographs
also have limitations [10, 11]. They provide only an
indirect measure of the disease process. Further-
more, radiographic progression is usually slow and
a long period time is needed to detect changes.
Recently several authors have emphasized the
need for precise standardization of the radiologi-
cal procedure [4, 12–15] in order to decrease the
noise and increase the signal-to-noise ratio which
improves of our capacity to detect changes using
plain radiographs. The results observed are closely
related to the characteristics of the studied
patients. Homogeneization of the presentation of
such results is required.Key points to consider
Tables I and II summarize the main factors
influencing joint space width measurement in knee
and hip OA. These factors can be used to facilitate
the analysis of presented results and/or the
planning of clinical studies.RADIOGRAPHIC TECHNIQUESReceived 3 December 1997; accepted 30 July 1998.
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Jacques, 75014 Paris.Standardization of radiographic procedures
Obtaining comparable radiographs on succes-
sive visits is a prerequisite for reliable assessment
of OA progression [4, 6, 10–12]. The lack of stand-
ardization of radiographic procedures and joint
positioning results in variable radiographic
images and compromises the measurement of
radiographic features and particularly of joint
space width (JSW) measurement [13, 14].
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sources of variability such as weight-bearing are
well known [16] and taken into account, while
others are frequently neglected. These other
sources of variability such as X-ray beam inclina-
tion, or foot rotation, which dramatically modifies
JSW measurement, must also be controlled [13].
Given the slight changes in JSW expected over
time, it is important to limit the sources of varia-
bility by standardization of the radiographic pro-
cedure and joint positioning in order to increase
the signal-to-noise ratio and to improve the capac-
ity to detect relevant changes. For this purpose,
the use of guidelines defining precisely the
process and a data form including key points to
record for the radiologist in order to repeat
the same X-ray on successive visits must be
encouraged [13, 14].Table I
Factors influencing joint space width assessment in knee OA
Patient positioning - Weight bearing or not
- Mono or bipodal
- Extended or flexed knee
- Foot rotation
- One knee or both knees
Radiographic procedure - Direction of ray beam
- X-ray beam angle
- Distance back of the knee to film
- Distance tube to film
Site of measurement - Medial or lateral compartment
- Plane of measurement (narrowest point or midpoint)
- Boundaries of measurement (distal convex margin of the
femoral condyle and floor of the tibial plateau)
Measuring methods - Quantitative or semi-quantitative methods
- Distance or area
- Automatic measurement or not
Reader - Training of the reader
- Number of readersTable II
Factors influencing joint space width assessment in hip OA
Patient positioning - Weight bearing or not
- Foot rotation
Radiographic procedure - One hip or both hips
- Direction of ray beam
- X-ray beam angle
- Distance centre of joint—film
- Distance tube to film
Site of measurement - Plane of measurement (narrowest point)
- Boundaries of measurement (superior convex margin of the
femoral head and inferior margin of the acetabulum)
Measuring methods - Quantitative or semi-quantitative methods
- Distance or area
- Automatic measurement or not
Reader - Training of the reader
- Number of readersChoice of views
For tibiofemoral OA, three di#erent views are
proposed: (i) anteroposterior extended view [4, 6,
13], (ii) anteroposterior semiflexed view [6, 14], and
(iii) posteroanterior flexed view [17–19] (Fig. 1).
For the semiflexed view, patients are required to
flex the knee to between 1) and 20) of flexion,
contrasting with the 30) to 45) of flexion required
for the flexed view [17–20]. The weight-bearing
areas in each tibial plateau vary depending on the
degree of knee flexion. During flexion, the weight-
bearing surfaces move backwards on the tibial
plateaux and become progressively smaller
[21–23]. During walking, the major contact
stresses in the tibiofemoral articulation occur
between 24) to 28) of knee flexion [22, 24] and the
weight-bearing area at 30) of flexion corresponds
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by arthroscopy [19]. Consequently the flexed view
has a high sensitivity to detect early stages of knee
osteoarthritis, and several authors have demon-
strated that in some cases, radiographs in full
extension are normal while the flexed view reveals
obvious joint space narrowing [17–19].
Concerning the choice of views in clinical trials
and epidemiological studies, several criteria must
be considered, including simplicity, reliability,
sensitivity to change and validity. Some data con-
cerning the radiographic reliability of hip and
knee radiographs are available [13, 25, 26]. Using
precise guidelines defining the radiographic
procedure, both the conventional extended view
and the semiflexed view appear reproducible with
SD in the measurement of JSW in the medial
compartment between radiographs taken on
several occasions varying between 0.11 mm and
0.38 mm according to the type of view, the method
of measurement and the magnification correction
[13, 26]. No data concerning the reproducibility of
the flexed view are available at this time. For the
flexed and semiflexed views, the use of fluoroscopy
is necessary to capture well the joint space [14].
The main di$culty in these two views is to repro-
duce the same angle of knee flexion. Furthermore,
the semiflexed view is anteroposterior, and the
distance between the centre of the joint and the
film increases during flexion. Therefore, correction
for radiographic magnification is necessary [14].
To correct the e#ect of radiographic magnification,the use of a metal sphere of known size taped
above the head of the fibula has been proposed
[6, 14]. However, the ability of the investigator to
reposition this sphere on precisely the same place
on successive X-ray visits remains questionable.
Data are needed to compare the relative value
(particularly sensitivity to change) of JSW
measurement using these di#erent views.
Hip anteroposterior pelvic radiographs and hip
radiographs are performed with feet internally
rotated (10&5)) [27]. The interest of weight bear-
ing hip radiographs is debated [4, 27]. In a recent
study comparing weight bearing and non-weight
bearing hip radiographs, a significant decrease in
JSW was observed only in the subgroup of patients
with joint space thickness less than 2.5 mm [28].
Others considered that internal rotation applies a
load to the articular surfaces and may be equiva-
lent to weight bearing radiographs [27]. Further-
more, in weight bearing positions, the bony joint
margins may appear blurred in obese patients.
More data are also needed to determine whether
views centered on one hip are superior to views
including both hips [27].Extended view Semi-flexed view Flexed view
FIG. 1. Di#erent views proposed to assess tibiofemoral osteoarthritis. Anteroposterior extended view is usually
performed with a craniocaudal X-ray beam angle of 5). Anteroposterior semiflexed view is performed with a
craniocaudal X-ray beam angle of 0) and with knees flexed to about 10). Posteroanterior flexed view is performed with
an X-ray beam angle of about 20) and with knees flexed to about 30).RADIOGRAPHIC FEATURES
According to recommendations of both the
GREES and the OARS [5, 6], assessment of struc-
tural changes should include both cartilage and
bone. Conventional X-rays show damage to bone
directly in the form of osteophytes, subchondral
Osteoarthritis and Cartilage Vol. 7 No. 2 225sclerosis and subchondral cysts, and damage to
cartilage indirectly through joint space narrow-
ing. At the present time, preservation of the integ-
rity of the articular cartilage is considered the
most important aspect of OA to be measured [29].
Consequently the primary endpoint in both epi-
demiologic studies and clinical trials is the joint
space width measured at the narrowest point [5, 6].
Osteophytes should also be assessed by grading
using a radiographic atlas [6, 30]. Progression over
a one-year period was more accurately assessed by
joint space width measurement than by scoring
using composite indexes such as the Kellgren &
Lawrence grading system [31, 32]. Current qualita-
tive methods of assessment are best at detecting
and counting new abnormalities, such as osteo-
phytes, but not as good at quantifying changes in
these abnormalities (e.g. increase in osteophyte
size). This is partially due to characteristics of the
scoring system that induce a floor or ceiling e#ect
at the extremes of measurement. Quantitative
methods of assessment should be more influenced
than qualitative methods by joint position and
radiographic procedure.
FACTORS AFFECTING DISEASE PROGRESSION
Osteoarthritis is a heterogeneous disorder and
many factors can a#ect the rate of progression of
the disease. These factors must be recorded at
entry in clinical trials or epidemiological studies.
They can also be used to define a subgroup of
patients at highest risk of rapid disease progres-
sion who are well suited for studies of structure-
modifying drugs [4–6]. These factors predisposing
to structural progression appear to be related to
the localization of osteoarthritis, i.e., factors pre-
disposing to rapid structural progression of medial
tibio-femoral OA are di#erent from those of
supero-lateral hip OA. It must be noted that to
assess knee OA progression, almost all studies are
based on extended view and moreover on extended
view performed without guidelines.
Demographic data
Recent studies showed that overweight persons
with knee osteoarthritis are at high risk of disease
progression [33, 34]. Spector shows that in middle
aged women with unilateral knee disease, obesity
has a clear e#ect on progression of osteophyte
score in the index joint with a relative risk of 4.7
for the upper BMI tertile [35]. Furthermore, in this
study 47% of women in the top BMI tertile
(BMI>26.4) developed OA defined by osteophytes
(Kellgren & Lawrence 2+) in the contralateralknee compared with 10% in the lowest tertile
(BMI<23.4) [35]. This subgroup of patients appears
to be an ideal population for studying therapeutic
measures to prevent OA [6, 34]. The role of obesity
in the progression of hip osteoarthritis remains
unclear [35]. Two recent studies failed to detect an
increased occurrence of radiographic progression
in hip OA in obese patients [9, 36). At variance, age
and sex have to be considered as factors associated
with a particularly rapid structural progression of
hip OA (the older the patient the more rapid the
progression; hip OA progresses more rapidly in
the female)
Characteristics of osteoarthritis
Localization. The intra-articular distribution of
the disease should be considered [4]. Medial and
lateral tibiofemoral OA should be considered as
di#erent disorders. For the hip, radiological pro-
gression appears related to the localization of
femoral head migration [9, 36]. Superolateral
migration of the femoral head is correlated with
rapid progression of the disease [36]. In contrast,
superomedial femoral head migration or medial
migration are associated with slow progression of
hip OA [36].
Structural severity. The severity of radiological
changes is also a predisposing factor for pro-
gression (the narrower the joint space width, the
more rapid is structural progression). However,
su$cient remaining joint space width (>2 mm at
the knee, >1 mm at the hip) is necessary to permit
detection of progression [36].
Symptomatic severity. Symptomatic severity of OA
evaluated by Lequesne’s functional index or per-
sistant pain is also predictive of radiological
progression. In several studies, the presence of
synovial e#usion appears related to progression
[33, 37]. Dieppe also suggested that the subchon-
dral bone activity detected by bone scintigraphy is
highly predictive of loss of tibiofemoral joint space
width [38].
Biological status
There is increasing interest in the analysis of
biochemical markers of cartilage and bone metab-
olism to study the disease processes in OA. Some
biochemical variables have been shown to be modi-
fied in patients with rapid structural progression
of the disease. These molecular markers could be
used to predict progression in OA. It has been
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levels, serum keratan sulfate, and serum cartilage
oligomeric matrix protein levels are associated
with rapid disease progression in osteoarthritis of
the knee joint [39–41]. The relevance of measure-
ments of these biochemical variables has to be
confirmed. At the present time, none of them can
be recommended as providing a measure of disease
progression. However, this field is developing
rapidly and new markers could emerge. The
potential of these markers has prompted the col-
lection and storage of body fluid samples (serum,
urine and joint fluid if possible) in clinical trials,
which will allow future analysis of these markers
[5, 6, 42].DESCRIPTION OF THE TIME COURSE OF THE DISEASE
Given the usually slow rate of articular carti-
lage loss, a period of at least several years is
considered necessary to detect significant radio-
logical progression. Radiographic damage is recog-
nized as being correlated significantly with
duration of disease, but little is known concerning
the time course of radiographic changes. It is
frequently assumed that radiographic progression
in OA is linear over time and that the cumulative
change observed is proportional to the duration of
the disease. Some data support that episodes of
anatomic chondrolysis are related to clinical flares
of the disease [33, 37, 43]. Therefore linear models
do not provide accurate representation of radio-
graphic damage over time in groups of OA
patients, and nonlinear models are probably more
appropriate.ResultsHOW TO PRESENT THEM?Categorical variables
Methods assessing the radiological progression
of OA using categorical variables such as the
Kellgren and Lawrence grading system or the size
of osteophytes permit definition of progression by
a change of at least one grade during the study.
The results should present the number of patients
with such a change. But these scales involve some
problems and limitations: the scales have a limited
range and may introduce a ceiling e#ect; these
scales are probably not linear over their range (for
example, concerning the Kellgren and Lawrence
grading scale, the di#erence between grade 1 and 2
is not equivalent to the di#erence between grade 3
and 4). Categorical variables may be used in pri-
mary prevention trials. In these studies, the resultsshould be presented as a dichotomous variable
(presence of OA radiographic lesion, Yes/No).Continuous variables
For these variables, the results should be pre-
sented as a mean change over the study (for
example, joint space width in mm), as a mean
change per unit of time (e.g. in mm/year), or as a
dichotomous variable (progression, Yes/No). In
this case it is necessary to establish a cut o# point
above which value obtained for change in the
continuous variable will define progression. The
determination of this cut o# point can be proposed
arbitrarily and/or using a consensual approach.
Dieppe et al. proposed for knee OA to define
progression as a change in joint space width
greater than 2 mn [44]. To be considered related to
the evolution of the disease, these changes over
time must exceed the variability inherent in repeat
radiographs and in the measurement process [11].
Consequently, we propose to determine a cut o#
based on these variabilities (re-radiographing,
reader, measuring instrument) by joint space
width measurements on radiographs repeated the
same day in a subgroup of patients representative
of the whole group. According to Bland & Altman,
most disagreements in JSW measurement between
two X-ray visits are expected to lie between
D&1.96 SD (for a risk Æ fixed at 5%) where D is
the mean di#erence between pairs of repeated
measurement obtained from repeated X-rays and
SD the standard deviation of this di#erence [45].
Assuming there is no organic change over the
period between two X-rays visits, D is expected
to be zero and we define "1.96 SD and +1.96 SD
as cut-o#s. Thus, we can assume that a change
superior to this cut o# probably reflects organic
change and not measurement error. This cut o# is
specific for a particular study and depends on the
care taken in joint positioning and radiographic
procedure, on the experience of readers and on
the reproducibility of the measuring instrument
chosen. It could be determined from a represen-
tative sample of patients included in the study. As
an example, in knee OA patients radiographed
twice with guidelines but without fluoroscopy, and
measuring JSW with a graduated magnifying glass
the cut-o# obtained was 0.64 mm [45].
As a general rule, an intention-to-treat (ITT)
analysis should be preferred in clinical trials. The
usual way to account for missing data is to use the
last observation carried forward (LOCF) technique
in which the last value observed under treatment
is used as the value of the end of the study period
where the date of this last value is either the end of
Osteoarthritis and Cartilage Vol. 7 No. 2 227the study for the completers, the last observation
at the date of withdrawal, or the last intermediate
value during the study. If the results are reported
as changes in absolute values between end-point
and baseline, this technique (LOCF) does not seem
to be appropriate since it may attenuate the rate
of progression in the withdrawal group. In our
opinion, two other techniques should be more
appropriate. The first consists in analyzing the
results using a dichotomous variable: progression
yes or no. This technique, as previously explained,
permits to consider a maximal bias for patients not
completing the study, i.e., considering them as
progressive whatever the reason for withdrawal.
This technique can be applied even in the absence
of any X-ray after baseline. The second one con-
sists in analysing the results by presenting them as
relative changes, i.e., mean changes per unit of
time. This technique has at least two flaws; (1) the
assumption of the linearity of structural pro-
gression and (2) the impossibility of calculating a
value for the patient with no after-baseline X-ray.
The latter remark emphasizes the requirement of
intermediate X-ray determination in a study in
which it is planned to apply this technique. Conse-
quently, it is important to plan an X-ray visit at
the time the patient discontinues the study drug,
whatever the reason.DATA AVAILABLE
Longitudinal studies of medial tibiofemoral OA
yields annual rates of JSN varying from 0.06–
0.60 mm/year [45]. In hip OA mean changes vary
from 0.22–0.33 mm/year [9, 47].
The di#erences between studies in terms of both
mean changes and standard deviations of the
changes are due to various factors: patient charac-
teristics, radiological procedure used, technique of
analysis, and concomitant therapies. However, it
has to be emphasized that the most recent studies
evaluating symptomatic active patients and using
appropriate tools suggest that statistically signifi-
cant changes can be observed within a relatively
short period of follow-up (1–2 years) and in a
relatively small sample size (50–100). This charac-
teristic is called ‘sensitivity to change’ and can be
expressed by calculating for a particular variable
the Standardized Response Mean (SRM) defined by
the ratio of the mean change of a continuous
variable during the study period over the standard
deviation of this change. It is accepted that an
SRM lower than 0.20 is not relevant and that at
variance an SRM over 0.60 is of great interest [48].
For example, after a one year follow-up period in
hip osteoarthritis, the SRM of joint space widthevaluated in millimeters is 0.37 [31], and it is 0.53
in the medial tibio-femoral compartment [32].
Considering the high percentage of withdrawals
observed in long term trials [44, 53], the lack of
data concerning the rate of OA progression beyond
the first year of follow up and the capacity to
detect changes after a one year follow-up period,
the duration of structural modification studies
in OA should probably be less than initially
proposed.COMPARISON TO OTHER TECHNIQUES
To measure structural changes in OA, various
methods have been proposed: plain radiographs,
microfocal radiographs, magnetic resonance imag-
ing (MRI) and arthroscopy. Comparison of the
relative interest of these di#erent methods must
take into account all properties ideally required
for a measuring instrument: simplicity (avail-
ability, time required, cost, invasive or not), repro-
ducibility, sensitivity to change, and validity.
Furthermore when comparing these di#erent
methods, we must take into account their con-
ditions of use. For example, it is di$cult to
compare nonstandardized plain X-rays with stan-
dardized microfocal X-rays, or fat-suppressed
three-dimensional gradient-echo MR imaging with
standard MR imaging. None of these methods
meets all the criteria and we must weigh all these
parameters before choosing one of the methods.
Microfocal X-ray o#ers the advantage of high
radiographic magnification without distortion and
therefore facilitates measurement. However, the
radiation dose is higher than in standard X-rays
[12]. Furthermore, this equipment is available in
only few centres and thus cannot be used in
multicentre studies.
MRI is a promising technique which can quan-
tify cartilage thickness or cartilage volume, probe
the composition of articular cartilage (water con-
tent) and examine other components of the joint [6,
8, 50]. A recent cross-sectional study gives informa-
tion on feasibility, validity and reproducibility of
quantitative MR imaging evaluation of chondropa-
thy in osteoarthritic knees [51]. Evaluation of the
sensitivity to change of this technique and com-
parison with plain radiographs require further
studies. The widespread use of MRI in clinical
trials is di$cult because of its limited availability.
Arthroscopy allows assessment of cartilage con-
dition by direct visualization and palpation and
provides information concerning other compo-
nents of the joint [6, 52]. Performed under local
anesthesia, arthroscopy is a relevant outcome
measure of OA in clinical research and could
228 Ravaud et al.: Radiologic progression of hip and knee osteoarthritispotentially lead to reducing the duration and
number of patients in clinical trials or DMOAD in
OA. However, arthroscopy remains an invasive
costly and time consuming procedure [52]. The
beneficial e#ect of concomitant articular lavage
systematically delivered during arthroscopy needs
to be considered when evaluating knee pain in
relation to OA progression.
Radiological assessment of joint space width on
plain radiographs remains the best non-invasive
method available for assessing disease progression
in OA. However, sources of variability in joint
space width measurement are numerous, and
standardization of radiographic technique and
joint positioning is essential to permit detection of
changes over time. Further studies are required to
evaluate the potential of views such as the flexed
view and to compare plain X-rays to other imaging
techniques.References
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